Arizona State Retirement System’s Arbutus Biopharma ABUS Stock Holding History

Arizona State Retirement System’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$189K	Sell	39,398 -222	-0.6%	-$975	﹤0.01%	1978
2026 Q1	$178K	Sell	39,620 -342	-0.9%	-$1.5K	﹤0.01%	1933
2025 Q4	$192K	Sell	39,962 -2,428	-6%	-$10.9K	﹤0.01%	1931
2025 Q3	$192K	Buy	42,390 +542	+1%	+$1.99K	﹤0.01%	1966
2025 Q2	$129K	Buy	41,848 +1,141	+3%	+$3.79K	﹤0.01%	1998
2025 Q1	$142K	Sell	40,707 -325	-0.8%	-$1.08K	﹤0.01%	1962
2024 Q4	$134K	Buy	41,032 +277	+0.7%	+$1.02K	﹤0.01%	2036
2024 Q3	$157K	Buy	+40,755	New	+$156K	﹤0.01%	2028

Other funds holding ABUS

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arizona State Retirement System's ABUS Position: Q2 2026 in Review

Arizona State Retirement System reduced its Arbutus Biopharma (ABUS) stake by 0.56% in Q2 2026, selling an estimated $975 and leaving 39,398 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

Arizona State Retirement System first reported a position in ABUS in Q3 2024 and has held it in 8 quarters since. The position peaked at $192K in Q3 2025. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

Arizona State Retirement System held 39,398 shares of Arbutus Biopharma worth $189K as of Q2 2026.
Arizona State Retirement System sold 222 Arbutus Biopharma shares in Q2 2026, an estimated $975.
Arbutus Biopharma made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1978 holding.
Arizona State Retirement System first reported a position in Arbutus Biopharma in Q3 2024 and has held it in 8 quarters since.
Arizona State Retirement System's Arbutus Biopharma position peaked at $192K in Q3 2025.
177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.